Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2C9 | P11712 | 1/20 | 0.35 |
| ▸ | EGFR | P00533 | 3/20 | 0.33 |
| ▸ | NPC1 | O15118 | 1/20 | 0.33 |
| ▸ | RAB9A | P51151 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | ATM | Q13315 | 1/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
| ▸ | FABP4 | P15090 | 5/20 | 0.32 |
| ▸ | FABP3 | P05413 | 3/20 | 0.32 |
| ▸ | MMP2 | P08253 | 1/20 | 0.32 |
| ▸ | RAC2 | P15153 | 1/20 | 0.32 |
| ▸ | RAC3 | P60763 | 1/20 | 0.32 |
| ▸ | CDC42 | P60953 | 1/20 | 0.32 |
| ▸ | RAC1 | P63000 | 1/20 | 0.32 |
| ▸ | USP8 | P40818 | 1/20 | 0.31 |
| ▸ | CNR1 | P21554 | 1/20 | 0.31 |
| ▸ | CNR2 | P34972 | 1/20 | 0.31 |
| ▸ | CYP1A1 | P04798 | 2/20 | 0.30 |
| ▸ | CYP1B1 | Q16678 | 2/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8735751 | 0.93 | CYP2C9 (0.37) | CYP2C9EGFRNPC1RAB9AFABP4 | |
| SCHEMBL23370606 | 0.86 | L3MBTL1 (0.40) | KDM4EATML3MBTL1 | |
| SCHEMBL18020697 | 0.86 | L3MBTL1 (0.40) | KDM4EATML3MBTL1 | |
| SCHEMBL18020680 | 0.86 | KDM4E (0.42) | KDM4EATML3MBTL1 | |
| SCHEMBL19061227 | 0.86 | L3MBTL1 (0.42) | KDM4EATML3MBTL1 | |
| SCHEMBL18020754 | 0.86 | KDM4E (0.44) | KDM4EATML3MBTL1 | |
| SCHEMBL12865725 | 0.86 | KDM4E (0.44) | KDM4EATML3MBTL1 | |
| SCHEMBL18086166 | 0.85 | L3MBTL1 (0.43) | KDM4EATML3MBTL1 | |
| SCHEMBL8734503 | 0.85 | KDM4E (0.37) | KDM4EATML3MBTL1 | |
| SCHEMBL14212272 | 0.84 | L3MBTL1 (0.42) | KDM4EATML3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9266851-B2 | Fluorene-containing aromatic compound, material for organic electroluminescent element, and organic electroluminescent element using same | IDEMITSU KOSAN CO., LTD. (JP) | 2016-02-23 | — | — | US | disclosed |
| US-9266851-B2 | Fluorene-containing aromatic compound, material for organic electroluminescent element, and organic electroluminescent element using same | IDEMITSU KOSAN CO., LTD. (JP) | 2016-02-23 | — | — | US | disclosed |
| US-20120126217-A1 | FLUORENE-CONTAINING AROMATIC COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENT, AND ORGANIC ELECTROLUMINESCENT ELEMENT USING SAME | IDEMITSU KOSAN CO. LTD. (JP) | 2012-05-24 | — | — | US | disclosed |
| US-20120126217-A1 | FLUORENE-CONTAINING AROMATIC COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENT, AND ORGANIC ELECTROLUMINESCENT ELEMENT USING SAME | IDEMITSU KOSAN CO. LTD. (JP) | 2012-05-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120126217-A1 | FLUORENE-CONTAINING AROMATIC COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENT, AND ORGANIC ELECTROLUMINESCENT ELEMENT USING SAME | NR0B2, AFF2, AFF1 | CYP2C9 401/4885EGFR 305/4885NPC1 556/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.